Urolithiasis associated with topiramate

Detalhes bibliográficos
Autor(a) principal: Eggener,Scott
Data de Publicação: 2004
Outros Autores: Kim,Samuel C., User,Herbert M., Pazona,Joseph, Nadler,Robert B.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: International Braz J Urol (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382004000100006
Resumo: OBJECTIVE: Topiramate is a sulfamate-substituted monosaccharide anticonvulsant used as adjunctive therapy for intractable refractory seizures. It is report a case of topiramate-induced urolithiasis. CASE REPORT: A 35-year-old man presented with acute, right-sided, colicky flank pain. He denied hematuria or dysuria. He was in use of phenytoin, risperidone, phenobarbital, and topiramate. The total daily dose of topiramate was 375 mg. A CT scan showed a 7 x 1 mm curvilinear density at the right ureterovesical junction with proximal hydrouretronephrosis. He was managed with rigid ureteroscopic stone extraction and the calculus metabolic analysis revealed the stone was composed of carbonate apatite (70%), calcium oxalate dihydrate (20%), and calcium oxalate monohydrate (10%). COMMENTS: The present case typifies many features of topiramate-induced urolithiasis. Those who care for patients with urinary stone disease should be aware of this association.
id SBU-1_fbdc14a1f08d919e7d1ad94b5e46e3da
oai_identifier_str oai:scielo:S1677-55382004000100006
network_acronym_str SBU-1
network_name_str International Braz J Urol (Online)
repository_id_str
spelling Urolithiasis associated with topiramateurolithiasisacidsmetabolismanticonvulsantsadverse effectsOBJECTIVE: Topiramate is a sulfamate-substituted monosaccharide anticonvulsant used as adjunctive therapy for intractable refractory seizures. It is report a case of topiramate-induced urolithiasis. CASE REPORT: A 35-year-old man presented with acute, right-sided, colicky flank pain. He denied hematuria or dysuria. He was in use of phenytoin, risperidone, phenobarbital, and topiramate. The total daily dose of topiramate was 375 mg. A CT scan showed a 7 x 1 mm curvilinear density at the right ureterovesical junction with proximal hydrouretronephrosis. He was managed with rigid ureteroscopic stone extraction and the calculus metabolic analysis revealed the stone was composed of carbonate apatite (70%), calcium oxalate dihydrate (20%), and calcium oxalate monohydrate (10%). COMMENTS: The present case typifies many features of topiramate-induced urolithiasis. Those who care for patients with urinary stone disease should be aware of this association.Sociedade Brasileira de Urologia2004-02-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382004000100006International braz j urol v.30 n.1 2004reponame:International Braz J Urol (Online)instname:Sociedade Brasileira de Urologia (SBU)instacron:SBU10.1590/S1677-55382004000100006info:eu-repo/semantics/openAccessEggener,ScottKim,Samuel C.User,Herbert M.Pazona,JosephNadler,Robert B.eng2004-05-21T00:00:00Zoai:scielo:S1677-55382004000100006Revistahttp://www.brazjurol.com.br/ONGhttps://old.scielo.br/oai/scielo-oai.php||brazjurol@brazjurol.com.br1677-61191677-5538opendoar:2004-05-21T00:00International Braz J Urol (Online) - Sociedade Brasileira de Urologia (SBU)false
dc.title.none.fl_str_mv Urolithiasis associated with topiramate
title Urolithiasis associated with topiramate
spellingShingle Urolithiasis associated with topiramate
Eggener,Scott
urolithiasis
acids
metabolism
anticonvulsants
adverse effects
title_short Urolithiasis associated with topiramate
title_full Urolithiasis associated with topiramate
title_fullStr Urolithiasis associated with topiramate
title_full_unstemmed Urolithiasis associated with topiramate
title_sort Urolithiasis associated with topiramate
author Eggener,Scott
author_facet Eggener,Scott
Kim,Samuel C.
User,Herbert M.
Pazona,Joseph
Nadler,Robert B.
author_role author
author2 Kim,Samuel C.
User,Herbert M.
Pazona,Joseph
Nadler,Robert B.
author2_role author
author
author
author
dc.contributor.author.fl_str_mv Eggener,Scott
Kim,Samuel C.
User,Herbert M.
Pazona,Joseph
Nadler,Robert B.
dc.subject.por.fl_str_mv urolithiasis
acids
metabolism
anticonvulsants
adverse effects
topic urolithiasis
acids
metabolism
anticonvulsants
adverse effects
description OBJECTIVE: Topiramate is a sulfamate-substituted monosaccharide anticonvulsant used as adjunctive therapy for intractable refractory seizures. It is report a case of topiramate-induced urolithiasis. CASE REPORT: A 35-year-old man presented with acute, right-sided, colicky flank pain. He denied hematuria or dysuria. He was in use of phenytoin, risperidone, phenobarbital, and topiramate. The total daily dose of topiramate was 375 mg. A CT scan showed a 7 x 1 mm curvilinear density at the right ureterovesical junction with proximal hydrouretronephrosis. He was managed with rigid ureteroscopic stone extraction and the calculus metabolic analysis revealed the stone was composed of carbonate apatite (70%), calcium oxalate dihydrate (20%), and calcium oxalate monohydrate (10%). COMMENTS: The present case typifies many features of topiramate-induced urolithiasis. Those who care for patients with urinary stone disease should be aware of this association.
publishDate 2004
dc.date.none.fl_str_mv 2004-02-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382004000100006
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382004000100006
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/S1677-55382004000100006
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Sociedade Brasileira de Urologia
publisher.none.fl_str_mv Sociedade Brasileira de Urologia
dc.source.none.fl_str_mv International braz j urol v.30 n.1 2004
reponame:International Braz J Urol (Online)
instname:Sociedade Brasileira de Urologia (SBU)
instacron:SBU
instname_str Sociedade Brasileira de Urologia (SBU)
instacron_str SBU
institution SBU
reponame_str International Braz J Urol (Online)
collection International Braz J Urol (Online)
repository.name.fl_str_mv International Braz J Urol (Online) - Sociedade Brasileira de Urologia (SBU)
repository.mail.fl_str_mv ||brazjurol@brazjurol.com.br
_version_ 1750318068675903488